[Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting].
CONCLUSION: The data presented do not justify a change of current treatment paradigms just yet. However, interesting developments can be expected in the coming years, particularly in the field of immunotherapy.
PMID: 30421001 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research
More News: Cancer | Cancer & Oncology | ENT & OMF | Erbitux | Genital Warts | Head and Neck Cancer | Human Papillomavirus (HPV) | Immunotherapy | Oral Cancer | Study